{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:33:36Z","timestamp":1793378016807,"version":"4.5.0"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.rmed.2026.109033","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T20:16:56Z","timestamp":1783628216000},"page":"109033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Asthma at the crossroads: From anti-TNF-\u03b1 setbacks to next-generation biologics targeting type 1 and type 2 inflammation"],"prefix":"10.1016","volume":"261","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5377-338X","authenticated-orcid":false,"given":"Vaibhavkumar","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Khera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurvir","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6644-7706","authenticated-orcid":false,"given":"Md Asif","family":"Khalid Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.rmed.2026.109033_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2024.100909","article-title":"Pediatric asthma comorbidities: global impact and unmet needs","volume":"17","author":"Hossny","year":"2024","journal-title":"World Allergy Organ. J."},{"issue":"2","key":"10.1016\/j.rmed.2026.109033_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/03007995.2018.1528218","article-title":"Uncontrolled severe asthma: starting from the unmet needs","volume":"35","author":"Caminati","year":"2018","journal-title":"Curr. Med. Res. Opin."},{"issue":"7","key":"10.1016\/j.rmed.2026.109033_bib3","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/children9071001","article-title":"Asthma comorbidities: frequency, risk factors, and associated burden in children and adolescents","volume":"9","author":"Fasola","year":"2022","journal-title":"Children"},{"issue":"7","key":"10.1016\/j.rmed.2026.109033_bib4","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.rmed.2006.03.031","article-title":"Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment","volume":"100","author":"Peters","year":"2006","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.rmed.2026.109033_bib5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4331\/wjbc.v8.i2.120","article-title":"Role of pro- and anti-inflammatory phenomena in the physiopathology of type 2 diabetes and obesity","volume":"8","author":"Pirola","year":"2017","journal-title":"World J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.rmed.2026.109033_bib6","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/joim.13345","article-title":"Twenty\u2010five years of biologicals in IBD: what's all the hype about?","volume":"290","author":"Herrlinger","year":"2021","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.rmed.2026.109033_bib7","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/039463200902200301","article-title":"Anti-TNF-alpha inhibitors: a new therapeutic approach for inflammatory immune-mediated diseases: an update upon efficacy and adverse events","volume":"22","author":"Murdaca","year":"2009","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"7","key":"10.1016\/j.rmed.2026.109033_bib8","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1164\/rccm.201809-1817PP","article-title":"Unmet needs in severe asthma subtyping and precision medicine trials. Bridging clinical and patient perspectives","volume":"199","author":"Siddiqui","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.109033_bib9","doi-asserted-by":"crossref","unstructured":"Jarab AS, Abu Heshmeh SR, Al Meslamani AZ. Bridging the gap: the future of biosimilars regulations. Hum. Vaccines Immunother. [Internet]. 20(1):2362450. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC11188803\/.","DOI":"10.1080\/21645515.2024.2362450"},{"issue":"Supplement_5","key":"10.1016\/j.rmed.2026.109033_bib10","doi-asserted-by":"crossref","first-page":"S363","DOI":"10.1513\/AnnalsATS.201703-231AW","article-title":"Metabolic dysregulation, systemic inflammation, and pediatric obesity-related asthma","volume":"14","author":"Rastogi","year":"2017","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"9","key":"10.1016\/j.rmed.2026.109033_bib11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00011-020-01378-2","article-title":"Macrophage polarization and its role in the pathogenesis of acute lung injury\/acute respiratory distress syndrome","volume":"69","author":"Chen","year":"2020","journal-title":"Inflamm. Res."},{"issue":"10221","key":"10.1016\/j.rmed.2026.109033_bib12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0140-6736(19)33005-3","article-title":"Intersection of biology and therapeutics: type 2 targeted therapeutics for adult asthma","volume":"395","author":"Peters","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.rmed.2026.109033_bib13","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.clinthera.2016.03.018","article-title":"Efficacy and safety profile of anti\u2013tumor necrosis Factor-\u03b1 versus anti-integrin agents for the treatment of Crohn's disease: a network meta-analysis of indirect comparisons","volume":"38","author":"Miligkos","year":"2016","journal-title":"Clin. Ther."},{"issue":"2","key":"10.1016\/j.rmed.2026.109033_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100502","article-title":"Biologics and global burden of asthma: a worldwide portrait and a call for action","volume":"14","author":"Caminati","year":"2021","journal-title":"World Allergy Organ. J."},{"issue":"S1","key":"10.1016\/j.rmed.2026.109033_bib15","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1002\/alr.21615","article-title":"Comorbidities of asthma and the unified airway","volume":"5","author":"Stachler","year":"2015","journal-title":"Int. Forum Allergy Rhinol."},{"issue":"83","key":"10.1016\/j.rmed.2026.109033_bib16","first-page":"243","article-title":"Asthma phenotypes and endotypes: an evolving paradigm for classification","volume":"15","author":"Corren","year":"2013","journal-title":"Discov. Med."},{"key":"10.1016\/j.rmed.2026.109033_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1629060","article-title":"The role of the tuft cell\u2013interleukin-25 axis in the pathogenesis of inflammatory bowel disease","volume":"16","author":"Tao","year":"2025","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.rmed.2026.109033_bib18","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1398-9995.2012.02865.x","article-title":"International consensus on (ICON) pediatric asthma","volume":"67","author":"Papadopoulos","year":"2012","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.rmed.2026.109033_bib19","first-page":"555","article-title":"Review of eight pharmacoeconomic studies of the value of biologic DMARDs adalimumab, etanercept, and infliximab) in the management of rheumatoid arthritis","volume":"12","author":"Doan","year":"2006","journal-title":"J. Manag. Care Pharm."},{"issue":"7","key":"10.1016\/j.rmed.2026.109033_bib20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/14712598.2024.2314612","article-title":"Streamlining biosimilar development based on 20 years' experience","volume":"24","author":"Nick","year":"2024","journal-title":"Expert Opin. Biol. Ther."},{"issue":"18","key":"10.1016\/j.rmed.2026.109033_bib21","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.3390\/jcm12185846","article-title":"Severe asthma and biological therapies: now and the future","volume":"12","author":"Olaia","year":"2023","journal-title":"J. Clin. Med."},{"issue":"8","key":"10.1016\/j.rmed.2026.109033_bib22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/17476348.2023.2254234","article-title":"Severe pediatric asthma endotypes: current limits and future perspectives","volume":"17","author":"Andrenacci","year":"2023","journal-title":"Expert Rev. Respir. Med."},{"issue":"9643","key":"10.1016\/j.rmed.2026.109033_bib23","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(08)61452-X","article-title":"Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease","volume":"372","author":"Anderson","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.rmed.2026.109033_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/imr.12555","article-title":"Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells","volume":"278","author":"Palomares","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.rmed.2026.109033_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.156091","article-title":"IL-4 and IL-13, not eosinophils, drive type 2 airway inflammation, remodeling and lung function decline","volume":"162","author":"Scott","year":"2023","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.rmed.2026.109033_bib26","doi-asserted-by":"crossref","DOI":"10.1007\/s12016-025-09045-2","article-title":"Targeting IL-13 and IL-4 in asthma: therapeutic implications on airway remodeling in severe asthma","volume":"68","author":"Sahnoon","year":"2025","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"168","key":"10.1016\/j.rmed.2026.109033_bib27","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0201-2022","article-title":"Phenotype overlap in the natural history of asthma","volume":"32","author":"Ricciardolo","year":"2023","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.rmed.2026.109033_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.coi.2020.10.002","article-title":"Mechanisms of non-type 2 asthma","volume":"66","author":"Hudey","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.rmed.2026.109033_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2222.1999.00006.x-i2","article-title":"The paradigm of type 1 and type 2 antigen-presenting cells. Implications for atopic allergy","volume":"29","author":"Kapsenberg","year":"1999","journal-title":"Clin. Exp. Allergy"},{"issue":"5","key":"10.1016\/j.rmed.2026.109033_bib30","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3390\/diagnostics12051175","article-title":"Neutrophils and asthma","volume":"12","author":"Yamasaki","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.rmed.2026.109033_bib31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jneuroim.2015.07.003","article-title":"Increased production of IL-17 in children with autism spectrum disorders and co-morbid asthma","volume":"286","author":"Eloi Akintunde","year":"2015","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.rmed.2026.109033_bib32","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat. Med."},{"issue":"9537","key":"10.1016\/j.rmed.2026.109033_bib33","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0140-6736(06)69288-X","article-title":"The mechanisms, diagnosis, and management of severe asthma in adults","volume":"368","author":"Holgate","year":"2006","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.rmed.2026.109033_bib34","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jaci.2015.01.026","article-title":"Distinct endotypes of steroid-resistant asthma characterized by IL-17Ahigh and IFN-\u03b3high immunophenotypes: potential benefits of calcitriol","volume":"136","author":"Chambers","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"issue":"26","key":"10.1016\/j.rmed.2026.109033_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aao4747","article-title":"Neutrophil cytoplasts induce TH17 differentiation and skew inflammation toward neutrophilia in severe asthma","volume":"3","author":"Krishnamoorthy","year":"2018","journal-title":"Sci. Immunol."},{"issue":"2","key":"10.1016\/j.rmed.2026.109033_bib36","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3390\/jcm13020526","article-title":"Asthma inflammatory phenotypes: how can we distinguish them?","volume":"13","author":"Plavsic","year":"2024","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.109033_bib37","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1378\/chest.103.4.997","article-title":"Intraepithelial dendritic cells and selective activation of Th2-Like lymphocytes in patients with atopic asthma","volume":"103","author":"Bellini","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2026.109033_bib38","author":"Steinbrink"},{"key":"10.1016\/j.rmed.2026.109033_bib39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/978-1-4757-9966-8_61","article-title":"A potential pathway of Th2 development during primary immune response","author":"Liu","year":"1997","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.rmed.2026.109033_bib40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12016-018-8712-1","article-title":"Understanding asthma phenotypes, endotypes, and mechanisms of disease","volume":"56","author":"Kuruvilla","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"2","key":"10.1016\/j.rmed.2026.109033_bib41","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00826-2023","article-title":"Advances in non-type 2 severe asthma: from molecular insights to novel treatment strategies","volume":"64","author":"Liu","year":"2024","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2026.109033_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1646711","article-title":"Elevated Th1 and terminally differentiated cytotoxic T cells with suppressed Tc17 lymphocytes in lung tissue of advanced COPD and IPF patients undergoing lung transplantation","volume":"16","author":"\u0160arc","year":"2025","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.rmed.2026.109033_bib43","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1634\/stemcells.20-5-448","article-title":"The role of PGE2 in the differentiation of dendritic cells: how do dendritic cells influence t\u2010cell polarization and chemokine receptor expression?","volume":"20","author":"Lee","year":"2002","journal-title":"Stem Cell."},{"issue":"10","key":"10.1016\/j.rmed.2026.109033_bib44","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.3390\/biomedicines9101497","article-title":"Strategies targeting type 2 inflammation: from monoclonal antibodies to JAK-inhibitors","volume":"9","author":"Matucci","year":"2021","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.rmed.2026.109033_bib45","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.3390\/jcm12041630","article-title":"Past, present and (Foreseeable) future of biological Anti-TNF alpha therapy","volume":"12","author":"Leone","year":"2023","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.109033_bib46","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2174\/1566524043360636","article-title":"Differential TNF-signaling in chronic inflammatory disorders","volume":"4","author":"Holtmann","year":"2004","journal-title":"Curr. Mol. Med."},{"issue":"12","key":"10.1016\/j.rmed.2026.109033_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/all.15473","article-title":"Biologics and airway remodeling in severe asthma","volume":"77","author":"Varricchi","year":"2022","journal-title":"Allergy"},{"issue":"22","key":"10.1016\/j.rmed.2026.109033_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214466","article-title":"Human lung mast cells: therapeutic implications in asthma","volume":"23","author":"Poto","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.rmed.2026.109033_bib49","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3390\/biom5031266","article-title":"NF-kappaB signaling in chronic inflammatory airway disease","volume":"5","author":"Schuliga","year":"2015","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.rmed.2026.109033_bib50","doi-asserted-by":"crossref","DOI":"10.3858\/emm.2011.43.1.004","article-title":"Mast cells play a key role in Th2 cytokine-dependent asthma model through production of adhesion molecules by liberation of TNF-\u03b1","volume":"43","author":"Chai","year":"2011","journal-title":"Exp. Mol. Med."},{"issue":"22","key":"10.1016\/j.rmed.2026.109033_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216042","article-title":"Bronchial asthma, airway remodeling and lung fibrosis as successive steps of one process","volume":"24","author":"Savin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.rmed.2026.109033_bib52","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2217\/imt.10.67","article-title":"Anti-TNF-\u03b1 agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls","volume":"2","author":"Silva","year":"2010","journal-title":"Immunotherapy"},{"issue":"4","key":"10.1016\/j.rmed.2026.109033_bib53","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/jcpt.12045","article-title":"Direct and indirect comparison of the efficacy and safety of adalimumab, etanercept, infliximab and golimumab in psoriatic arthritis","volume":"38","author":"F\u00e9nix-Caballero","year":"2013","journal-title":"J. Clin. Pharm. Therapeut."},{"issue":"7","key":"10.1016\/j.rmed.2026.109033_bib54","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.autrev.2012.10.021","article-title":"Immunogenicity and autoimmunity during anti-TNF therapy","volume":"12","author":"Atzeni","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.rmed.2026.109033_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.793409","article-title":"Biologics in asthma: a molecular perspective to precision medicine","volume":"12","author":"Salter","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.rmed.2026.109033_bib56","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1080\/1744666X.2025.2514604","article-title":"Mechanisms and therapeutic potential of epithelial-immune crosstalk in airway inflammation","volume":"21","author":"Chen","year":"2025","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"9","key":"10.1016\/j.rmed.2026.109033_bib57","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1111\/jdv.19135","article-title":"Efficacy of anti\u2010IL\u201023 and anti\u2010IL\u201017 after adalimumab failure in psoriatic patients","volume":"37","author":"Mastorino","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.rmed.2026.109033_bib58","article-title":"Association between psoriasis and chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"10","author":"Li","year":"2015"},{"key":"10.1016\/j.rmed.2026.109033_bib59","doi-asserted-by":"crossref","DOI":"10.4081\/dr.2023.9692","article-title":"Anti-IL17 and anti-IL23 biologic drugs for genital psoriasis: a single-center retrospective comparative study","author":"Cortese","year":"2023","journal-title":"Dermatol. Rep."},{"issue":"19","key":"10.1016\/j.rmed.2026.109033_bib60","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.3390\/cancers17193105","article-title":"Decision-making biomarkers guiding therapeutic strategies in hepatocellular carcinoma: from prediction to personalized care","volume":"17","author":"Liu","year":"2025","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.rmed.2026.109033_bib61","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.3390\/ijms23031767","article-title":"Chronic inflammation as the underlying mechanism of the development of lung diseases in psoriasis: a systematic review","volume":"23","author":"Mleczko","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.rmed.2026.109033_bib62","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00364-2019","article-title":"The role of interleukin-17 in asthma: a protective response?","volume":"6","author":"Hynes","year":"2020","journal-title":"ERJ Open Res."},{"key":"10.1016\/j.rmed.2026.109033_bib63","author":"Wang"},{"issue":"5","key":"10.1016\/j.rmed.2026.109033_bib64","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s40265-024-02028-1","article-title":"Elke, van. Drug survival of IL-17 and IL-23 inhibitors for psoriasis: a systematic review and meta-analysis","volume":"84","author":"Thomas","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.rmed.2026.109033_bib65","article-title":"JAK-STAT pathway, type I\/II cytokines, and new potential therapeutic strategy for autoimmune bullous diseases: update on pemphigus vulgaris and bullous pemphigoid","volume":"16","author":"Lin","year":"2025","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.rmed.2026.109033_bib66","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nri1226","article-title":"Regulation of JAK-STAT signalling in the immune system","volume":"3","author":"Shuai","year":"2003","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.rmed.2026.109033_bib67","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.tips.2020.06.007","article-title":"Targeting JAK-STAT signaling to control cytokine release syndrome in COVID-19","volume":"41","author":"Luo","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.rmed.2026.109033_bib68","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/1744666X.2022.2039122","article-title":"Recent issues in JAK inhibitor safety: perspective for the clinician","volume":"18","author":"Fleischmann","year":"2022","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"26","key":"10.1016\/j.rmed.2026.109033_bib69","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1182\/blood.2021013379","article-title":"A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK\/STAT targeting in T-cell lymphomas","volume":"138","author":"Moskowitz","year":"2021","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.rmed.2026.109033_bib70","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1007\/s00018-012-0989-2","article-title":"Type I IFN-mediated regulation of IL-1 production in inflammatory disorders","volume":"69","author":"Ludigs","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.rmed.2026.109033_bib71","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nri3133","article-title":"Immunomodulatory functions of type I interferons","volume":"12","author":"Gonz\u00e1lez-Navajas","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.rmed.2026.109033_bib72","first-page":"353","article-title":"Crosstalk with the Jak-STAT pathway in inflammation","author":"Ivashkiv","year":"2012","journal-title":"Jak Stat Signal. : From Basics Dis."},{"issue":"6","key":"10.1016\/j.rmed.2026.109033_bib73","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1083\/jcb.201602089","article-title":"The cell biology of inflammasomes: mechanisms of inflammasome activation and regulation","volume":"213","author":"Sharma","year":"2016","journal-title":"JCB (J. Cell Biol.)"},{"issue":"1","key":"10.1016\/j.rmed.2026.109033_bib74","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/imr.12289","article-title":"Bacterial recognition pathways that lead to inflammasome activation","volume":"265","author":"Storek","year":"2015","journal-title":"Immunol. Rev."},{"issue":"29","key":"10.1016\/j.rmed.2026.109033_bib75","doi-asserted-by":"crossref","first-page":"48507","DOI":"10.18632\/oncotarget.17397","article-title":"Implementing liquid biopsies into clinical decision making for cancer immunotherapy","volume":"8","author":"Quandt","year":"2017","journal-title":"Oncotarget"},{"issue":"18","key":"10.1016\/j.rmed.2026.109033_bib76","doi-asserted-by":"crossref","first-page":"6438","DOI":"10.3390\/molecules28186438","article-title":"Therapeutic antibodies in medicine","volume":"28","author":"Sharma","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.rmed.2026.109033_bib77","article-title":"The potential role of nanobodies in asthma therapy","volume":"15","author":"Khalid","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.rmed.2026.109033_bib78","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00260-2020","article-title":"Anti-alarmins in asthma: targeting the airway epithelium with next-generation biologics","volume":"56","author":"Porsbjerg","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2026.109033_bib79","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/pharmaceutics13020177","article-title":"Inhaled RNA therapeutics for obstructive airway diseases: recent advances and future prospects","volume":"13","author":"Xu","year":"2021","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.rmed.2026.109033_bib80","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3390\/ph17081059","article-title":"Nanoparticle-based drug delivery systems in inhaled therapy: improving respiratory medicine","volume":"17","author":"Cojocaru","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.rmed.2026.109033_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02663","article-title":"Therapeutic application of mesenchymal stem cells derived extracellular vesicles for immunomodulation","volume":"10","author":"Gomzikova","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.rmed.2026.109033_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.570672","article-title":"Using gene editing approaches to fine-tune the immune system","volume":"11","author":"Pavlovic","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.rmed.2026.109033_bib83","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12450","article-title":"Group 2 ILCs: a way of enhancing immune protection against human helminths?","volume":"40","author":"Nausch","year":"2017","journal-title":"Parasite Immunol."},{"issue":"11","key":"10.1016\/j.rmed.2026.109033_bib84","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.3390\/biomedicines9111684","article-title":"Characterization of T2-Low and T2-High asthma phenotypes in real-life","volume":"9","author":"Ricciardolo","year":"2021","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.rmed.2026.109033_bib85","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jaci.2022.06.012","article-title":"Modulation of IL-4\/IL-13 cytokine signaling in the context of allergic disease","volume":"150","author":"Shankar","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2026.109033_bib86","article-title":"Therapeutic potential of TNF\u03b1 inhibitors in chronic inflammatory disorders: past and future","author":"Zhang","year":"2020","journal-title":"Genes Dis."},{"issue":"4","key":"10.1016\/j.rmed.2026.109033_bib87","doi-asserted-by":"crossref","first-page":"2301619","DOI":"10.1183\/13993003.01619-2023","article-title":"Airway remodelling in asthma and the epithelium: on the edge of a new era. European respiratory journal","volume":"63","author":"Varricchi","year":"2024","journal-title":"Eur. Respiratory J."},{"key":"10.1016\/j.rmed.2026.109033_bib88","article-title":"Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases","volume":"22","author":"Kolkhir","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2026.109033_bib89","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/1744666X.2020.1858803","article-title":"Efficacy and safety of subcutaneous infliximab versus adalimumab, etanercept and intravenous infliximab in patients with rheumatoid arthritis: a systematic literature review and meta-analysis","volume":"17","author":"Caporali","year":"2020","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"4","key":"10.1016\/j.rmed.2026.109033_bib90","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.coph.2009.04.008","article-title":"Anti-inflammatory and pro-inflammatory roles of TGF-\u03b2, IL-10, and IL-22 in immunity and autoimmunity","volume":"9","author":"Sanjabi","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.rmed.2026.109033_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114112","article-title":"The management of severe asthma in 2020","volume":"179","author":"C\u00f4t\u00e9","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.rmed.2026.109033_bib92","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s40259-013-0020-y","article-title":"Development and regulation of biosimilars: current status and future challenges","volume":"27","author":"Tsiftsoglou","year":"2013","journal-title":"BioDrugs"},{"issue":"5","key":"10.1016\/j.rmed.2026.109033_bib93","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/2050640615590302","article-title":"Biologics in inflammatory bowel disease: what are the data?","volume":"3","author":"C\u00f4t\u00e9-Daigneault","year":"2015","journal-title":"United Eur. Gastroenterol. J."},{"issue":"20","key":"10.1016\/j.rmed.2026.109033_bib94","doi-asserted-by":"crossref","first-page":"12049","DOI":"10.1074\/jbc.271.20.12049","article-title":"Mitogen-activated protein kinase in neutrophils and enucleate neutrophil cytoplasts: evidence for regulation of cell-cell adhesion","volume":"271","author":"Pillinger","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.rmed.2026.109033_bib95","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaci.2016.10.034","article-title":"Identification of IL-17F\/frequent exacerbator endotype in asthma","volume":"140","author":"Ricciardolo","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.rmed.2026.109033_bib96","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/all.13985","article-title":"Mechanisms and therapeutic strategies for non\u2010T2 asthma","volume":"75","author":"Sze","year":"2019","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.rmed.2026.109033_bib97","doi-asserted-by":"crossref","DOI":"10.4081\/monaldi.2024.3079","article-title":"Combination treatment with monoclonal antibodies for the management of severe asthma and immune-mediated inflammatory diseases: a comprehensive review","volume":"95","author":"Carriera","year":"2025","journal-title":"Monaldi Arch. Chest Dis."},{"issue":"11","key":"10.1016\/j.rmed.2026.109033_bib98","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3390\/jpm13111594","article-title":"Combination of biological therapy in severe asthma: where we are?","volume":"13","author":"Carriera","year":"2023","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.rmed.2026.109033_bib99","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2147\/JAA.S507008","article-title":"Combining dual biologics therapy for severe asthma: a series of ten cases","volume":"18","author":"Chen","year":"2025","journal-title":"J. Asthma Allergy"},{"issue":"1","key":"10.1016\/j.rmed.2026.109033_bib100","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cpt.893","article-title":"Anti-IL-23 and Anti-IL-17 biologic agents for the treatment of immune-mediated inflammatory conditions","volume":"103","author":"Frieder","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.rmed.2026.109033_bib101","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12072-018-9919-1","article-title":"Goals and targets for personalized therapy for HCC","volume":"13","author":"Couri","year":"2019","journal-title":"Hepatol. Int."},{"issue":"2","key":"10.1016\/j.rmed.2026.109033_bib102","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.immuni.2011.02.006","article-title":"Type I interferon inhibits Interleukin-1 production and inflammasome activation","volume":"34","author":"Guarda","year":"2011","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.rmed.2026.109033_bib103","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1749-6632.1998.tb08309.x","article-title":"Immunomodulatory properties of Interferon\u2010\u03b3: an update a","volume":"856","author":"Billiau","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.rmed.2026.109033_bib104","article-title":"Pharmacokinetic considerations of inhaled pharmaceuticals for sys","author":"Hu","year":"2016","journal-title":"Ingenta Connect"},{"key":"10.1016\/j.rmed.2026.109033_bib105","first-page":"1","article-title":"The emergence of inhalable RNA therapeutics and challenges faced - where to from here?","author":"Haque","year":"2024","journal-title":"Nanomedicine"},{"key":"10.1016\/j.rmed.2026.109033_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.00997","article-title":"Mesenchymal stem cell-derived extracellular vesicles: opportunities and challenges for clinical translation","volume":"8","author":"Maumus","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"3","key":"10.1016\/j.rmed.2026.109033_bib107","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/nph.19020","article-title":"Beyond knockouts: fine\u2010tuning regulation of gene expression in plants with CRISPR\u2010Cas\u2010based promoter editing","volume":"239","author":"Tang","year":"2023","journal-title":"New Phytol."},{"key":"10.1016\/j.rmed.2026.109033_bib108","article-title":"Innovative formulations for controlled drug delivery to the lungs\u2026","author":"Aragao-Santiago","year":"2016","journal-title":"Ingenta Connect"},{"key":"10.1016\/j.rmed.2026.109033_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2024.05.027","article-title":"A novel inhalable nanobody targeting IL-4R\u03b1 for the treatment of asthma","author":"Zhu","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.rmed.2026.109033_bib110","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3390\/ijms20030713","article-title":"A novel insight on endotyping heterogeneous severe asthma based on endoplasmic reticulum stress: beyond the \u201cType 2\/Non-Type 2 Dichotomy.\u201d","volume":"20","author":"Jeong","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.rmed.2026.109033_bib111","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2567.2008.03010.x","article-title":"Review series on helminths, immune modulation and the hygiene hypothesis: immunity against helminths and immunological phenomena in modern human populations: coevolutionary legacies?","volume":"126","author":"Jackson","year":"2009","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.rmed.2026.109033_bib112","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1636","article-title":"Novel bispecific nanobody mitigates experimental intestinal inflammation in mice by targeting TNF\u2010\u03b1 and IL\u201023p19 bioactivities","volume":"14","author":"Wang","year":"2024","journal-title":"Clin. Transl. Med."},{"issue":"10","key":"10.1016\/j.rmed.2026.109033_bib113","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.tips.2020.08.002","article-title":"Inhaled RNA therapy: from promise to reality","volume":"41","author":"Chow","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.rmed.2026.109033_bib114","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/17425247.2016.1244187","article-title":"Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures","volume":"14","author":"Ragelle","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.rmed.2026.109033_bib115","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-019-0137-8","article-title":"Gene editing for immune cell therapies","author":"Bailey","year":"2019","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.rmed.2026.109033_bib116","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1756-8722-5-19","article-title":"Clinical applications of mesenchymal stem cells","volume":"5","author":"Wang","year":"2012","journal-title":"J. Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.rmed.2026.109033_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2023.05.028","article-title":"Comprehensive characterization of difficult-to-treat asthma reveals near absence of T2-Low status","volume":"11","author":"Rupani","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"1","key":"10.1016\/j.rmed.2026.109033_bib118","article-title":"Anti\u2013IL-4Ra therapy is superior to other biologic classes in treating allergic bronchopulmonary aspergillosis","volume":"4","author":"Lamothe","year":"2024","journal-title":"J. Allergy Clin. Immunol.: Global"},{"key":"10.1016\/j.rmed.2026.109033_bib119","article-title":"Biologics and airway remodeling in asthma: early, late, and potential preventive effects","author":"Varricchi","year":"2024","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.rmed.2026.109033_bib120","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/all.15609","article-title":"Sounding the alarmins\u2014The role of alarmin cytokines in asthma","volume":"78","author":"Gauvreau","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2026.109033_bib121","doi-asserted-by":"crossref","DOI":"10.2174\/0115748863360017250509063745","article-title":"Biosimilar regulations: current framework and future prospects","volume":"20","author":"Kaur","year":"2025","journal-title":"Curr. Drug Saf."},{"issue":"3","key":"10.1016\/j.rmed.2026.109033_bib122","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4161\/cbt.5.3.2526","article-title":"Biological therapies: twenty-five years of progress in cancer therapy","volume":"5","author":"Foon","year":"2006","journal-title":"Cancer Biol. Ther."},{"issue":"9","key":"10.1016\/j.rmed.2026.109033_bib123","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.3390\/biomedicines9091108","article-title":"Monoclonal antibodies targeting alarmins: a new perspective for biological therapies of severe asthma","volume":"9","author":"Pelaia","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.rmed.2026.109033_bib124","doi-asserted-by":"crossref","DOI":"10.1089\/hum.2023.210","article-title":"The new frontiers of gene therapy and gene editing in inflammatory diseases","author":"Romano","year":"2024","journal-title":"Hum. Gene Ther."},{"issue":"6","key":"10.1016\/j.rmed.2026.109033_bib125","doi-asserted-by":"crossref","first-page":"601","DOI":"10.4168\/aair.2024.16.6.601","article-title":"Clinical characteristics of T2-Low and T2-High asthma-chronic obstructive pulmonary disease overlap: findings from COREA cohort","volume":"16","author":"Shim","year":"2024","journal-title":"Allergy Asthma Immunol. Res."},{"issue":"2","key":"10.1016\/j.rmed.2026.109033_bib126","doi-asserted-by":"crossref","DOI":"10.4254\/wjh.v17.i2.101201","article-title":"Strategies for discovering novel hepatocellular carcinoma biomarkers","volume":"17","author":"Wu","year":"2025","journal-title":"World J. Hepatol."},{"issue":"5","key":"10.1016\/j.rmed.2026.109033_bib127","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jaci.2007.06.031","article-title":"Asthma therapy and airway remodeling","volume":"120","author":"Mauad","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2026.109033_bib128","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2018.12.004","article-title":"Progression in migraine: role of mast cells and pro-inflammatory and anti-inflammatory cytokines","volume":"844","author":"Conti","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"68","key":"10.1016\/j.rmed.2026.109033_bib129","article-title":"Pathophysiological mechanisms of asthma","volume":"7","author":"Bush","year":"2019","journal-title":"Front. Pediatr."},{"issue":"5","key":"10.1016\/j.rmed.2026.109033_bib130","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1172\/JCI33342","article-title":"The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice","volume":"118","author":"Guo","year":"2008","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.rmed.2026.109033_bib131","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/08916930903510880","article-title":"Recent advances on the immunomodulatory effects of IFN-\u03b1: implications for cancer immunotherapy and autoimmunity","volume":"43","author":"Rizza","year":"2010","journal-title":"Autoimmunity"},{"issue":"1","key":"10.1016\/j.rmed.2026.109033_bib132","doi-asserted-by":"crossref","DOI":"10.1186\/1465-9921-11-78","article-title":"Interleukin-17 regulation: an attractive therapeutic approach for asthma","volume":"11","author":"Park","year":"2010","journal-title":"Respir. Res."},{"issue":"7","key":"10.1016\/j.rmed.2026.109033_bib133","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/bios14070356","article-title":"AI-Assisted detection of biomarkers by sensors and biosensors for early diagnosis and monitoring","volume":"14","author":"Wasilewski","year":"2024","journal-title":"Biosensors"},{"key":"10.1016\/j.rmed.2026.109033_bib134","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2024.1496392","article-title":"Unraveling heterogeneity and treatment of asthma through integrating multi-omics data","volume":"5","author":"Zhang","year":"2024","journal-title":"Front. Allergy"},{"key":"10.1016\/j.rmed.2026.109033_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2024.108420","article-title":"An integrated new approach methodology for inhalation risk assessment of safe and sustainable by design nanomaterials","volume":"183","author":"Motta","year":"2024","journal-title":"Environ. Int."},{"issue":"3","key":"10.1016\/j.rmed.2026.109033_bib136","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/ATVBAHA.122.318331","article-title":"Digital twins for predictive, preventive personalized, and participatory treatment of immune-mediated diseases","volume":"43","author":"Benson","year":"2023","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.rmed.2026.109033_bib137","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3748\/wjg.v29.i2.272","article-title":"Advancing the precision management of inflammatory bowel disease in the era of omics approaches and new technology","volume":"29","author":"Liu","year":"2023","journal-title":"World J. Gastroenterol."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126004014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126004014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:38:34Z","timestamp":1793374714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126004014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":137,"alternative-id":["S0954611126004014"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109033","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asthma at the crossroads: From anti-TNF-\u03b1 setbacks to next-generation biologics targeting type 1 and type 2 inflammation","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109033"}}